Skip to Content

AR (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint AR is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; gerd; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AR

Rabeprazole sodium delayed-release 20 mg AR
Rabeprazole sodium delayed-release 20 mg AR
Rabeprazole sodium delayed-release 20 mg AR

Rabeprazole Sodium Delayed-Release

Imprint:
AR
Strength:
20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Amneal Pharmaceuticals of New York, LLC
National Drug Code (NDC):
65162-0724

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide